RUNX2 and acute myeloid leukemia: These findings indicate that EPZ004777 may modulate the expression of key regulatory genes in a cell line-dependent manner, with AML3 showing greater sensitivity to the effects of EPZ004777 on gene expression, which could have therapeutic implications for targeting specific genetic pathways in AML.